204 related articles for article (PubMed ID: 33333412)
1. Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma.
Megahed SM; Habib AA; Hammad SF; Kamal AH
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 249():119241. PubMed ID: 33333412
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum.
Eryavuz Onmaz D; Abusoglu S; Onmaz M; Yerlikaya FH; Unlu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122768. PubMed ID: 34052564
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma.
Hailat M; Al-Ani I; Hamad M; Zakareia Z; Abu Dayyih W
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206357
[TBL] [Abstract][Full Text] [Related]
4. Core-shell nanocomposite of flower-like molybdenum disulfide nanospheres and molecularly imprinted polymers for electrochemical detection of anti COVID-19 drug favipiravir in biological samples.
Wang S; Wang C; Xin Y; Li Q; Liu W
Mikrochim Acta; 2022 Mar; 189(3):125. PubMed ID: 35229221
[TBL] [Abstract][Full Text] [Related]
5. Eco-friendly novel deconvoluted synchronous spectrofluorimetric approach for the determination of favipiravir, levodropropizine and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in laboratory prepared mixtures and spiked human plasma.
Madbouly EA; El-Shanawani AA; El-Adl SM; Abdelkhalek AS
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Mar; 309():123823. PubMed ID: 38181621
[TBL] [Abstract][Full Text] [Related]
6. Menthol-assisted homogenous liquid-liquid microextraction for HPLC/UV determination of favipiravir as an antiviral for COVID-19 in human plasma.
Abdallah IA; Hammad SF; Bedair A; Mansour FR
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1189():123087. PubMed ID: 34974319
[TBL] [Abstract][Full Text] [Related]
7. Favipiravir for COVID-19 in a Patient on Hemodialysis.
Hirai D; Yamashita D; Seta K
Am J Kidney Dis; 2021 Jan; 77(1):153-154. PubMed ID: 33011311
[No Abstract] [Full Text] [Related]
8. Determination of favipiravir in human plasma using homogeneous liquid-liquid microextraction followed by HPLC/UV.
Abdallah IA; Hammad SF; Bedair A; Elshafeey AH; Mansour FR
Bioanalysis; 2022 Feb; 14(4):205-216. PubMed ID: 35001648
[No Abstract] [Full Text] [Related]
9. Synchronous spectrofluorimetric determination of favipiravir and aspirin at the nano-gram scale in spiked human plasma; greenness evaluation.
Batubara AS; Ainousah BE; Ramzy S; Abdelazim AH; Gamal M; Tony RM
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Oct; 299():122880. PubMed ID: 37216820
[TBL] [Abstract][Full Text] [Related]
10. Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens.
Mikhail IE; Elmansi H; Belal F; Ehab Ibrahim A
Microchem J; 2021 Jun; 165():106189. PubMed ID: 33776146
[TBL] [Abstract][Full Text] [Related]
11. Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma.
Ramzy S; Abdelazim AH; Osman AO; Hasan MA
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121625. PubMed ID: 35863184
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Analytical Procedure for In-hospital Rapid Quantification of Serum Level of Favipiravir in the Pharmacological Treatment of COVID-19.
Moriiwa Y; Morikawa G; Okazawa K; Yanagida A
Anal Sci; 2021 Sep; 37(9):1301-1304. PubMed ID: 33612558
[TBL] [Abstract][Full Text] [Related]
13. Conventional and synchronous spectrofluorometric determination of the recently administered drugs for treatment of COVID-19 favipiravir and apixaban.
Elama HS; Zeid AM; Shalan SM; El-Shabrawy Y; Eid MI
Sci Rep; 2022 Dec; 12(1):21520. PubMed ID: 36513795
[TBL] [Abstract][Full Text] [Related]
14. A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers.
Morsy MI; Nouman EG; Abdallah YM; Zainelabdeen MA; Darwish MM; Hassan AY; Gouda AS; Rezk MR; Abdel-Megied AM; Marzouk HM
J Pharm Biomed Anal; 2021 May; 199():114057. PubMed ID: 33831737
[TBL] [Abstract][Full Text] [Related]
15. Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen.
Sharaf YA; El Deeb S; Ibrahim AE; Al-Harrasi A; Sayed RA
Molecules; 2022 Apr; 27(7):. PubMed ID: 35408729
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
Habler K; Brügel M; Teupser D; Liebchen U; Scharf C; Schönermarck U; Vogeser M; Paal M
J Pharm Biomed Anal; 2021 Mar; 196():113935. PubMed ID: 33548872
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of favipiravir and hydroxychloroquine as FDA-approved drugs for treatment of COVID-19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluids.
El Sharkasy ME; Tolba MM; Belal F; Walash M; Aboshabana R
Luminescence; 2022 Jun; 37(6):953-964. PubMed ID: 35343627
[TBL] [Abstract][Full Text] [Related]
18. Spectrofluorimetric determination of the anti-Covid 19 agent, remdesivir, in vials and spiked human plasma.
Attia TZ; Boushra JM; Abdel Hakiem AF; Lashien AS; Noureldeen DAM
Luminescence; 2022 Jul; 37(7):1192-1199. PubMed ID: 35548893
[TBL] [Abstract][Full Text] [Related]
19. Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma.
Elmansi H; Ibrahim AE; Mikhail IE; Belal F
Anal Methods; 2021 Jun; 13(23):2596-2602. PubMed ID: 34019051
[TBL] [Abstract][Full Text] [Related]
20. Eco-friendly spectrophotometric methods for determination of remdesivir and favipiravir; the recently approved antivirals for COVID-19 treatment.
Elama HS; Zeid AM; Shalan SM; El-Shabrawy Y; Eid MI
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Feb; 287(Pt 2):122070. PubMed ID: 36403556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
